| The rapid development of small and medium-sized enterprises has become an important force to boost China’s economy,and plays an important role in the economic development of all countries in the world.With the continuous development of high-tech industry,biotechnology SMEs as an important part of the economic development process to maintain a strong vitality,with high technology content,large capital investment,long R &D cycle and other characteristics.At present,the domestic small and medium-sized biotechnology enterprises generally have the problems of poor financing channels,small scale and low financing efficiency.Therefore,it is of great practical significance to study the factors influencing the financing of small and medium-sized biotechnology enterprises.In the above context,this paper takes the financing ability of small and Medium-Sized Biotechnology Enterprises as a perspective,using a variety of research methods such as literature research,theoretical analysis and empirical analysis,to analyze the factors affecting the financing of small and medium-sized biotechnology enterprises,and explore ways to improve their financing efficiency.In the research process,we selected the biotechnology SMEs of Guangzhou Guanhao life and Health Science Park as the research sample,get 60 biological science and technology small and medium-sized enterprises(smes)in 2017 and2018 valid data,and multiple linear regression method is used to quantitatively study the related factors influencing the financing ability.The results show that the main factors are debt paying ability,mortgage ability,technological innovation ability and intellectual property cashing ability.The mortgage ability of enterprises is significantly positively correlated with the asset-liability ratio,indicating that the mortgage asset value ratio of biotechnology companies will have an obvious effect on the exogenous financing ability of enterprises.The technological innovation ability of enterprises is positively correlated with the asset-liability ratio.There is a significant positive correlation between the realization ability of intellectual property and the asset-liability ratio.From the results of theoretical analysis and empirical analysis,this paper puts forward specific plans to improve the financing of small and medium-sized biotechnology enterprises from various aspects,which mainly include improving the ability of enterprises to repay debts and innovate in science and technology,and strengthening the ability of enterprises to mortgage assets and intellectual property. |
